BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8097289)

  • 21. In vivo binding of (3H)Ro 15-1788 in mice: comparison with the in vivo binding of (3H)flunitrazepam.
    Potier MC; Prado de Carvalho L; Dodd RH; Brown CL; Rossier J
    Life Sci; 1988; 43(16):1287-96. PubMed ID: 2845217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dementia of the Alzheimer's type: changes in hippocampal L-[3H]glutamate binding.
    Greenamyre JT; Penney JB; D'Amato CJ; Young AB
    J Neurochem; 1987 Feb; 48(2):543-51. PubMed ID: 2878980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distribution of kainate receptor subunit mRNAs in human hippocampus, neocortex and cerebellum, and bilateral reduction of hippocampal GluR6 and KA2 transcripts in schizophrenia.
    Porter RH; Eastwood SL; Harrison PJ
    Brain Res; 1997 Mar; 751(2):217-31. PubMed ID: 9099808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hippocampal benzodiazepine receptors in schizophrenia.
    Reynolds GP; Stroud D
    J Neural Transm Gen Sect; 1993; 93(2):151-5. PubMed ID: 8217052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benzodiazepine receptors increase in post-mortem brain of chronic schizophrenics.
    Kiuchi Y; Kobayashi T; Takeuchi J; Shimizu H; Ogata H; Toru M
    Eur Arch Psychiatry Neurol Sci; 1989; 239(2):71-8. PubMed ID: 2553417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased binding of [3H]muscimol and [3H]flunitrazepam in the rat brain under hypoxia.
    Ninomiya H; Taniguchi T; Kameyama M; Fujiwara M
    J Neurochem; 1988 Oct; 51(4):1111-7. PubMed ID: 2843604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benzodiazepine binding sites in the cingulate cortex after lesion of the noradrenaline and dopamine containing afferents.
    Marcel D; Weissmann D; Bardelay C; Meunier C; Pujol JF
    Brain Res Bull; 1987 Oct; 19(4):485-94. PubMed ID: 2825929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential pharmacological properties of GABAA/benzodiazepine receptor complex in dorsal compared to ventral rat hippocampus.
    Sarantis K; Sotiriou E; Papatheodoropoulos C; Matsokis N; Angelatou F
    Neurochem Int; 2008 May; 52(6):1019-29. PubMed ID: 18069090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mapping of benzodiazepine-like immunoreactivity in the rat brain as revealed by a monoclonal antibody to benzodiazepines.
    Sánchez MP; Dietl MM; De Blas AL; Palacios JM
    J Chem Neuroanat; 1991; 4(2):111-21. PubMed ID: 1647785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benzodiazepine binding sites: localization and characterization in the limbic system of the rat brain.
    Marcel D; Weissmann-Nanopoulos D; Mach E; Pujol JF
    Brain Res Bull; 1986 May; 16(5):573-96. PubMed ID: 3017515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebellar benzodiazepine receptors: cellular localization and consequences of neurological mutations in mice.
    Rotter A; Frostholm A
    Brain Res; 1988 Mar; 444(1):133-46. PubMed ID: 2834020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distribution of central omega 1 (benzodiazepine1) and omega 2 (benzodiazepine2) receptor subtypes in the monkey and human brain. An autoradiographic study with [3H]flunitrazepam and the omega 1 selective ligand [3H]zolpidem.
    Dennis T; Dubois A; Benavides J; Scatton B
    J Pharmacol Exp Ther; 1988 Oct; 247(1):309-22. PubMed ID: 2845057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regional changes in [3H]zolpidem binding to brain benzodiazepine receptors in flurazepam tolerant rat: comparison with changes in [3H]flunitrazepam binding.
    Wu Y; Rosenberg HC; Chiu TH; Ramsey-Williams V
    J Pharmacol Exp Ther; 1994 Feb; 268(2):675-82. PubMed ID: 8113978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies.
    Perry DC; Dávila-García MI; Stockmeier CA; Kellar KJ
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1545-52. PubMed ID: 10336551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low levels of muscarinic M1 receptor-positive neurons in cortical layers III and V in Brodmann areas 9 and 17 from individuals with schizophrenia.
    Scarr E; Hopper S; Vos V; Seo MS; Everall IP; Aumann TD; Chana G; Dean B
    J Psychiatry Neurosci; 2018 Aug; 43(5):338-346. PubMed ID: 30125244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ionotropic glutamate receptor binding in the posterior cingulate cortex in schizophrenia patients.
    Newell KA; Zavitsanou K; Huang XF
    Neuroreport; 2005 Aug; 16(12):1363-7. PubMed ID: 16056140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the solubilized GABA and benzodiazepine receptors from various regions of bovine brain.
    Asano T; Yamada Y; Ogasawara N
    J Neurochem; 1983 Jan; 40(1):209-14. PubMed ID: 6294247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Propofol modulation of [3H]flunitrazepam binding to GABAA receptors in guinea pig cerebral cortex.
    Bruner KR; Reynolds JN
    Brain Res; 1998 Sep; 806(1):122-5. PubMed ID: 9739122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clathrin-coated vesicles from bovine brain contain uncoupled GABAA receptors.
    Tehrani MH; Baumgartner BJ; Barnes EM
    Brain Res; 1997 Nov; 776(1-2):195-203. PubMed ID: 9439813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoradiographic study on [3H]flunitrazepam binding in rat cortex and hippocampus after chronic ethanol treatment.
    Negro M; Fernández A; Calvo P
    Neurochem Res; 1992 Apr; 17(4):381-5. PubMed ID: 1513422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.